Nanalysis
Canadian scientific instrument company specializing in compact nuclear magnetic resonance spectroscopy and related magnetic-resonance technologies.
Last updated October 14, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Nanalysis Scientific Corp., marketed as Nanalysis, is a Canadian scientific-instrument company headquartered in Calgary, Alberta. Established in 2009, it focuses on making nuclear magnetic resonance (NMR) spectroscopy more compact, accessible, maintainable, and suitable for routine use outside the traditional high-field laboratory environment. Its core products are benchtop NMR spectrometers, including the NMReady family, which use permanent magnets and integrated software to provide chemical-analysis capabilities in a smaller and more operationally straightforward format than conventional superconducting NMR systems. The company’s business proposition is based on bringing NMR closer to the point of use. Conventional high-field NMR instruments can deliver very high resolution but generally require substantial capital investment, specialized infrastructure, trained operators, and ongoing maintenance. Nanalysis’s benchtop instruments are intended to reduce those barriers. They can support multinuclear measurements and one- and two-dimensional NMR experiments, while also being configured for more specialized analytical workflows. This makes them relevant to universities and teaching laboratories as well as industrial users in sectors such as oil and gas, chemicals, pharmaceuticals, biotechnology, food processing, cannabis, mining, and other regulated or process-oriented industries. Nanalysis introduced its first product, the 60 MHz NMReady benchtop NMR spectrometer, in 2013. The product was presented as the first portable, high-resolution 60 MHz benchtop NMR spectrometer on the market. Its compact design, relatively low maintenance requirements, automation potential, and simplified operation were intended to broaden access to NMR for undergraduate education, quality control, process development, and routine chemical identification. Rather than competing solely as a lower-cost substitute for the most powerful research instruments, the company positioned benchtop NMR as a complementary technology for measurements that can be performed closer to production, teaching, or testing environments. In 2019, Nanalysis announced a 100 MHz spectrometer. The higher magnetic field expanded the range of molecules and analytical tasks that could be resolved using benchtop NMR and represented an effort to extend the capabilities of permanent-magnet systems. The company has also emphasized the flexibility of its instruments: systems may be used as general-purpose spectrometers or configured as application-specific analyzers for particular industrial workflows. Nanalysis became a public company in 2019, with trading on the TSX Venture Exchange under the symbol NSCI. It later traded on the Frankfurt Stock Exchange under the symbol 1N1. The company has developed a global sales network and has reported instrument sales in more than 45 countries. Its Calgary base combines corporate, product-development, and manufacturing activities, while international distribution and service relationships support customers in multiple scientific and industrial markets. The company has broadened beyond its original benchtop-instrument focus through acquisitions and strategic investments. It acquired RS2D, a French magnetic-resonance technology company whose Cam4 platform supports products ranging from high-field NMR replacement consoles to preclinical and clinical MRI systems. In 2021, Nanalysis acquired One Moon Scientific, the developer of NMRfx software for magnetic-resonance data processing, analysis, and management. In 2022, it added K’Prime as a subsidiary to strengthen scientific-instrument sales and service capabilities, with operations associated with Phoenix and Calgary. Nanalysis also acquired a 43 percent interest in Quad Systems in 2022, creating a relationship aimed at combining complementary expertise in high-field NMR and compact magnetic-resonance products. Nanalysis therefore operates across hardware, software, service, and magnetic-resonance technology. Its brand identity is centered on practical accessibility: providing instruments and workflows that allow more organizations to use NMR without relying exclusively on large centralized facilities. The company remains active as a public scientific-technology business, with its portfolio extending from portable and benchtop spectroscopy into broader magnetic-resonance platforms and analytical software.
History
Nanalysis was established in Calgary, Alberta, in 2009 as a scientific-instrument company focused on compact nuclear magnetic resonance technology. Its founding business challenge was to make NMR more practical for organizations that did not need, or could not justify, the infrastructure associated with large superconducting high-field instruments. The company developed benchtop systems based on permanent magnets, integrated electronics, and software intended to simplify operation and reduce maintenance demands. The company’s first major commercial product arrived in 2013: the 60 MHz NMReady benchtop NMR spectrometer. It was described as the first portable, high-resolution 60 MHz benchtop NMR spectrometer introduced to the market. The system was designed to support multinuclear experiments as well as one- and two-dimensional NMR measurements. Its compact form factor allowed NMR to be considered for undergraduate teaching, routine chemical characterization, process monitoring, quality control, and other applications where access to a centralized research facility could slow down work. Nanalysis’s early market approach treated benchtop NMR as both an accessible alternative for routine work and a complement to high-field NMR. The company highlighted ease of use, affordability, low maintenance, automation, and deployment flexibility. Potential users included chemical, pharmaceutical, biotechnology, oil and gas, food-processing, cannabis, mining, and other industrial organizations. Instruments could be sold as general-purpose spectrometers or adapted into analyzers for defined workflows and sample types. In 2019, the company announced a 100 MHz benchtop spectrometer. The higher field strength was intended to improve resolution and extend the range of compounds that could be examined with permanent-magnet benchtop NMR. That same year, Nanalysis became a public company and began trading on the TSX Venture Exchange under the symbol NSCI. It later obtained a listing on the Frankfurt Stock Exchange under the symbol 1N1. Public-market access supported the company’s efforts to expand its product portfolio, sales network, and magnetic-resonance technology activities. The business subsequently broadened through acquisitions. RS2D became part of the Nanalysis portfolio, bringing the Cam4 magnetic-resonance platform and expertise in systems that could serve high-field NMR as well as preclinical and clinical MRI markets. RS2D had been founded in 2004 and was associated with the development of cryogen-free superconducting-magnet technology for preclinical imaging, including an early rodent MRI system based on that approach. Through RS2D, Nanalysis extended beyond portable spectroscopy into consoles, controls, and wider magnetic-resonance infrastructure. In 2021, Nanalysis acquired One Moon Scientific. The transaction added NMRfx, a software environment directed at magnetic-resonance data processing, analysis, and management for small and macromolecules. The software business complemented the company’s hardware by addressing the interpretation and organization of NMR data, including advanced processing, database, and machine-learning-oriented applications. In 2022, Nanalysis added K’Prime as a subsidiary. K’Prime provided scientific-instrument sales and service capabilities for customers in areas including security, pharmaceuticals, oil and gas, food, and chemical production, with operations associated with Phoenix and Calgary. The same year, Nanalysis took a 43 percent interest in Quad Systems. The investment was intended to combine complementary expertise and support innovation in high-field NMR while preserving a broader portfolio of compact and high-performance magnetic-resonance products. By expanding into software, service, magnetic-resonance consoles, and related imaging technologies, Nanalysis evolved from a focused benchtop-NMR manufacturer into a broader magnetic-resonance technology group. The company has maintained Calgary as its corporate, product-development, and manufacturing base while serving customers through an international sales network. It has reported sales in more than 45 countries. Its continuing strategic theme is to make NMR and associated magnetic-resonance workflows more deployable, automated, and accessible across education, research, industrial testing, and regulated production environments.
- 2022
Expansion into sales, service, and high-field NMR
[1]Nanalysis adds K’Prime as a subsidiary and acquires a 43 percent interest in Quad Systems.
- 2021
One Moon Scientific acquisition
[1]Nanalysis acquires One Moon Scientific and adds the NMRfx magnetic-resonance software portfolio.
- 2019
Public-market listing and 100 MHz announcement
[1]Nanalysis begins trading on the TSX Venture Exchange under NSCI and announces a 100 MHz benchtop NMR spectrometer.
- 2013
Launch of the 60 MHz NMReady
[1]Nanalysis introduces the 60 MHz NMReady benchtop NMR spectrometer, supporting multinuclear and one- and two-dimensional NMR measurements.
- 2009
Nanalysis is established in Calgary
[1]Nanalysis is established as a Canadian scientific-instrument company focused on compact NMR technology.
Products and positioning
Nanalysis positions itself around accessible, compact, lower-maintenance, and automatable NMR and magnetic-resonance systems. Its products are designed to complement high-field laboratory equipment by bringing chemical analysis and magnetic-resonance workflows to teaching laboratories, industrial sites, quality-control environments, and other settings where large conventional instruments may be impractical.
Benchtop NMR spectrometer · 2013
NMReady 60 MHz
Nanalysis’s first major commercial instrument, introduced in 2013. The NMReady 60 MHz is a portable, high-resolution benchtop NMR spectrometer designed for multinuclear measurements and one- and two-dimensional NMR experiments. Its compact format, simplified operation, and reduced maintenance requirements support use in education, routine chemical analysis, industrial laboratories, process development, and quality-control environments.
Benchtop NMR spectrometer · 2019
Nanalysis 100 MHz
A higher-field benchtop NMR platform announced in 2019. The system was intended to increase the range of molecules and analytical problems that could be resolved with a permanent-magnet benchtop instrument. It reflects Nanalysis’s effort to combine compact deployment with capabilities closer to those expected from more powerful laboratory spectroscopy systems.
NMR software
NMRfx
Software associated with One Moon Scientific and added to the Nanalysis portfolio in 2021. NMRfx is intended to streamline magnetic-resonance data processing, analysis, and management for small and macromolecules. Its capabilities include high-performance processing and tools associated with machine learning and database search or construction.
Magnetic-resonance control platform
RS2D Cam4
A magnetic-resonance technology platform from RS2D, acquired by Nanalysis. Cam4 supports a range of applications, including high-field NMR replacement consoles and preclinical or clinical MRI systems. Its inclusion gives Nanalysis capabilities beyond benchtop spectroscopy and links the company to broader magnetic-resonance system architecture and control.
Brand decisions
2022
Expand through K’Prime and Quad SystemsM&ABackground
Nanalysis pursued broader commercial coverage and complementary technology for compact and high-field magnetic-resonance markets.
Action taken
Nanalysis added K’Prime as a subsidiary and took a 43 percent stake in Quad Systems.
Aftermath
The moves expanded sales and service capabilities and created a technology relationship aimed at developing a wider range of magnetic-resonance products.
2021
Acquire One Moon ScientificM&ABackground
Nanalysis sought to broaden its magnetic-resonance offering from instruments into data processing, analysis, and management.
Action taken
The company acquired One Moon Scientific and its NMRfx software activities.
Aftermath
The acquisition added software capabilities for small- and macromolecule NMR analysis and supported a more integrated hardware-and-software portfolio.
2019
Introduce a 100 MHz benchtop NMR platformProduct launchBackground
Nanalysis sought to extend the analytical range of permanent-magnet benchtop NMR beyond its earlier 60 MHz offering.
Action taken
The company announced a 100 MHz spectrometer designed to resolve a broader range of molecules and applications.
Aftermath
The announcement strengthened Nanalysis’s position in higher-performance benchtop spectroscopy, although the available reference material does not provide subsequent sales or financial results.
Recent events
- 2022
Nanalysis expands through K’Prime and a Quad Systems investment[1]
M&A
Nanalysis added K’Prime as a subsidiary and took a 43 percent stake in Quad Systems, expanding sales and service capabilities while developing complementary magnetic-resonance technologies.
- 2021
Nanalysis acquires One Moon Scientific and NMRfx[1]
M&A · Product launch
Nanalysis acquired One Moon Scientific, adding NMRfx software capabilities for magnetic-resonance data processing, analysis, and management.
- 2019
Nanalysis begins trading as a public company on the TSX Venture Exchange[1]
Other
Nanalysis became a publicly traded company on the TSX Venture Exchange under the ticker NSCI, marking a transition from a privately held scientific-instrument manufacturer to a listed company.
- 2019
Nanalysis announces a 100 MHz benchtop NMR spectrometer[1]
Product launch · Product generation
The company announced a 100 MHz benchtop NMR system intended to broaden the molecules and analytical applications that could be addressed with permanent-magnet benchtop spectroscopy.
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/nanalysis · Editorial policy · How profiles are compiled